Cancer services
Health and Social Care Committee
Closed
Inquiry
This inquiry will ask why cancer outcomes in England continue to lag behind comparable countries internationally and examine evidence relating to the underlying causes of these differences. We will also consider what impact disruption to cancer services during the covid-19 pandemic will have on efforts to catch up, and ask …
Read more
15
Recommendations
15
Conclusions
1
Report
5
Oral sessions
3
Letters
5
Events
Activity timeline 15 events
13 Jun
2022
2022
5 Apr
2022
2022
Report published
29 Mar
2022
2022
25 Jan
2022
2022
20 Jan
2022
2022
Oral evidence
20 Jan
2022
2022
Formal meeting (oral evidence session) · The Grimond Room, Portcullis House
9 Nov
2021
2021
Oral evidence
9 Nov
2021
2021
Formal meeting (oral evidence session) · Room 8, Palace of Westminster
26 Oct
2021
2021
Oral evidence
26 Oct
2021
2021
Formal meeting (oral evidence session) · Room 5, Palace of Westminster
19 Oct
2021
2021
14 Sep
2021
2021
Oral evidence
Oral evidence sessions 5 sessions
20 Jan 2022
View on parliament.uk
Dame Cally Palmer · NHS England
Judith Neptial, cancer patient
Maria Caulfield · Department of Health and Social Care
Mark Foulkes · Royal Berkshire NHS Foundation Trust
Professor Peter Johnson · NHS England
William Vineall · Department of Health and Social Care
9 Nov 2021
View on parliament.uk
Anna Jewell · Less Survivable Cancers Taskforce
Ian Vousden · Kent and Medway Cancer Alliance
Jane Lyons · Cancer52
Katy Hall, Expert by experience
Professor David Baldwin · School of Medicine (University of Nottingham)
Professor David Shackley · Greater Manchester Cancer
Sarah Stevens · National Disease Registration Service, NHS Digital
26 Oct 2021
View on parliament.uk
Baroness Delyth Morgan · Breast Cancer Now
David Watson · The Association of the British Pharmaceutical Industry (ABPI)
Dr Philippa Hetherington, Expert by experience
Professor David Cunningham · Association of Cancer Physicians
Professor Mike Griffin · Royal College of Surgeons of Edinburgh
Professor Nick James · Institute of Cancer Research
Professor Pat Price · Action Radiotherapy
14 Sep 2021
View on parliament.uk
Andrea Brady, person with lived experience
Dr Andrew Millar · North Central London Cancer Alliance
Dr Jeanette Dickson · Council of the Academy of Medical Royal Colleges
Dr Richard Roope · Royal College of General Practitioners
Michelle Mitchell · Cancer Research UK
Professor Peter Sasieni · King's College London, Clinical Trials Unit
Sir Harpal Kumar · GRAIL Europe
13 Jul 2021
View on parliament.uk
Dame Cally Palmer · NHS England
John Butler · International Cancer Benchmarking Partnership
Prof Jon Emery · University of Melbourne
Prof Peter Johnson · NHS England
Prof Sir Mike Richards, Former National Cancer Director
Reports 1 report · click to expand
| Title | HC No. | Published | Items | Response |
|---|---|---|---|---|
| Twelfth Report - Cancer services | HC 551 | 5 Apr 2022 | 30 | Responded |
Recommendations & Conclusions
4 results
19
Conclusion
Deferred
Twelfth Report - Cancer services
Major specialist cancer hospitals have better access to staff, expertise and technology, and patients referred...
Major specialist cancer hospitals have better access to staff, expertise and technology, and patients referred to these sites are more likely to be offered potentially life- saving surgery. During the pandemic, these hospitals were the ones most likely to be …
Read more
Government Response
The government's response states the Cancer Call for Evidence has closed, and the responses are being analysed alongside wider evidence for a new vision for cancer care in their 10-Year Cancer Plan.
Department of Health and Social Care
View details
20
Recommendation
Deferred
Twelfth Report - Cancer services
As part of the Government’s new cancer plan, the Government and NHS England should review...
As part of the Government’s new cancer plan, the Government and NHS England should review the organisation of cancer surgery with a specific focus on whether more specialist hospitals should be established to ensure that more cancer surgery is carried …
Read more
Government Response
The government deferred action, stating that the Cancer Call for Evidence is being analysed and the 10-Year Cancer Plan will address the organisation of cancer surgery.
Department of Health and Social Care
View details
26
Conclusion
Deferred
Twelfth Report - Cancer services
There are specific challenges facing people with rare and less common and less survivable cancers,...
There are specific challenges facing people with rare and less common and less survivable cancers, including that they are often harder to diagnose and that issues with spreading best practice for treating less common cancers are more pronounced. Despite some …
Read more
Government Response
The government is analysing responses to the Cancer Call for Evidence to develop the 10 Year Cancer Plan, which will address all cancer types, including rare and less survivable cancers.
Department of Health and Social Care
View details
27
Recommendation
Deferred
Twelfth Report - Cancer services
The Government must consider rare, less common and less survivable cancers specifically as part of...
The Government must consider rare, less common and less survivable cancers specifically as part of its new cancer plan. NHS England should also produce an action plan for rare, less common and less survivable cancers, containing clear commitments to address …
Read more
Government Response
The government deferred action, stating that it is analysing responses to the Cancer Call for Evidence and that the 10 Year Cancer Plan will address all cancer types, including rare and less survivable cancers.
Department of Health and Social Care
View details
Correspondence 3 letters
29 Mar 2022
Corresondence from the National Cancer Director on the Cancer services inquiry
Parliament page
25 Jan 2022
To committee
Letter from the National Cancer Director and National Clinical Director on Cancer services dated 17.01.22
Parliament page
19 Oct 2021
To committee
Letter from Jeanette Dickson providing further information requested by the Committee on Cancer services dated 28.09.21
Parliament page